EUVIMED · CrossrefJournal
European Journal of Pharmaceutical Sciences
ISSN 0928-0987 · Elsevier BV
Latest articles
Toxicological effects of polyethylene terephthalate microplastics on chronic kidney disease: an integrative bioinformatics, network toxicology, and machine learning study
Application of the LeiCNS-PK model to quantitatively evaluate the roles of BBB active influx and brain metabolism of fluvoxamine and its serotonin transporter (SERT) occupancy in rat and human
A mechanistic pharmacokinetic–patient-derived organoid (PK–PDO) framework for comparing oxaliplatin HIPEC regimens in peritoneal metastases of colorectal cancer
Design, synthesis, in silico studies, and biological evaluation of N4-acetyl/benzoyl piperazinyl ciprofloxacin–amino acid conjugates as broad-spectrum antimicrobial agents
Folding free energy and evolution guided rational engineering of arginine deiminase enables enhanced catalytic efficiency, structural robustness, and antitumor efficacy
An industrial data-calibrated mechanistic modelling framework for robust operation and QbD design-space analysis in pharmaceutical fluid-bed drying
Development and temporal validation of a risk prediction model for piperacillin/tazobactam induced thrombocytopenia in older patients
Nano-in-Gel platforms for the topical treatment of Staphylococcus aureus skin infections
Identification of an NNK-associated gene signature and tumor microenvironmental features in head and neck squamous cell carcinoma
Revisiting the literature on gastric CBD-to-THC conversion: contextualizing conflicting evidence
Sustained drug exposure drives efficacy in mice: PK/PD analysis of corallopyronin a against wolbachia using physiologically based absorption modeling
Novel dual-targeted gastrin-releasing peptide receptor and fibroblast activation protein radiopharmaceuticals for molecular imaging of heterogeneous breast tumors
Understanding and controlling the sources of variability in pMDI plume temperature measurements
M4 drug discovery: Human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonist
Pharmacokinetic properties of the clinical drug candidate PRI-002 with regard to genotype, sex, age, dose-dependence and food effects in mice
Lipid nanoparticles for ursodeoxycholic acid delivery: A strategy for topical applications
Artificial intelligence–driven multi-omics analysis reveals hydroxytyrosol targeting of the TXNIP–NLRP3 inflammasome axis in traumatic brain injury
Navigating patient access pathways for non-viral RNA-based therapeutics: a comparative review of health technology assessment and reimbursement pathways across six countries
The top-down Finite Time Pharmacokinetic (FTPK) models vis-a-vis the bottom-up PBPK models in early drug development
Multifunctional electrospun PVA nanofibrous membrane loaded with CPFS-derived Zn-doped hydroxyapatite for osteochondral regeneration
Transitioning from impinging jets to single-jet impaction: investigation of an alternative nozzle design for the Respimat® Soft Mist Inhaler
Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells
Pharmacokinetics, safety, and efficacy of high-concentration intratympanic dexamethasone for sudden sensorineural hearing loss: An integrated non-human primate and clinical study
Corrigendum to “Evaluation of transduction properties and vaccine efficacy of a simian adenovirus type 25-based vector” [European Journal of Pharmaceutical Sciences 225 (2026)107619]
Systematic evaluation of propofol population pharmacokinetic models and development of a literature-supported new meta-model for critically ill preterm and term neonates
Novel inhibitors of BCRP found among drugs used in the treatment of cancer
Pirfenidone lung distribution amplified in idiopathic pulmonary fibrosis: Roles of tight junction disruption and drug transporter dysregulation
Nanostructures: Designed by nature – a brief history of Synthetic Amorphous Silica (SAS)
Overcoming formulation challenges of a moisture-sensitive API using tricalcium citrate TB and anhydrous trimagnesium citrate in direct compression
Unconventional molecular descriptors for blood-brain barrier permeability prediction: a unified model and its implications for local anesthetic design, micellar formulation, and chelation-based effect modification
Volumes
2027 · 82026 · 3422025 · 3912024 · 2962023 · 2672022 · 2482021 · 3732020 · 3852019 · 3592018 · 5102017 · 5442016 · 3662015 · 2932014 · 3052013 · 3042012 · 3072011 · 2462010 · 2372009 · 2442008 · 2852007 · 2822006 · 2122005 · 2112004 · 2302003 · 1952002 · 1652001 · 1602000 · 1221999 · 1051998 · 4551997 · 1561996 · 4981995 · 471994 · 4801993 · 26
EUVIMED